COVID-19 Updates
News
NYC public hospitals rose to the demands of the COVID-19 crisis
“We hospitalists, and all those recruited to act as hospitalists, essentially took responsibility for the COVID response.”
From the Journals
SARS-CoV-2 appears unlikely to pass through breast milk
Researchers detected viral RNA in a breast milk sample from one woman with COVID-19 disease, but culture was negative.
Commentary
Mitigating psychiatric disorder relapse in pregnancy during pandemic
The most common reasons for consultation on our service continue to be the appropriate, safest use of antidepressants and mood stabilizers during...
News from the FDA/CDC
FDA approves point-of-care COVID-19 antigen test
“This new COVID-19 antigen test is an important addition to available tests because the results can be read in minutes, right off the testing card...
Conference Coverage
COVID-19 vaccine supply will be limited at first, ACIP says
The working group expects that from 15 to 45 million doses of vaccine will be available by the end of December, depending on which vaccine is...
From the Journals
Asymptomatic SARS-CoV-2 infections in kids tied to local rates
It is unclear how many children remain asymptomatic in comparison with those who were in a presymptomatic phase at the time of testing.
Latest News
Convalescent plasma actions spark trial recruitment concerns
“It’s not clear that people with COVID-19, especially those who are severely ill and hospitalized, will choose to enlist in a clinical trial –...
News
Prognosis for rural hospitals worsens with pandemic
It’s a dangerous scenario. “We know that a closure leads to higher mortality pretty quickly” among the populations served.
Article
Reported COVID-19 symptoms by hospitalization status
Feature
When viruses collide: Flu season during pandemic
Seasonal flu in the midst of the COVID-19 pandemic threatens to overwhelm practitioners, hospitals and the health care system.
News from the FDA/CDC
FDA approves clinical trials for cannabinoid drug designed to reduce COVID-19 lung inflammation
The drug going to clinical trials, ARDS-003, would “dampen the cytokine release” and prevent development of ARDS.